The article "Artificial Intelligence in Academic Writing and Clinical Pharmacy Education: Consequences and Opportunities" by Anita Elaine Weidmann explores the ongoing debate surrounding the use of artificial intelligence (AI) in academic research and teaching. The launch of ChatGPT in November 2022 has sparked discussions on ethical considerations, academic integrity, authorship, and the need for new legal frameworks. AI tools can enhance time efficiency, promote critical thinking, and improve drug discovery, clinical decision-making, and guideline development, potentially benefiting patient safety. However, concerns about plagiarism, authorship, and the need for adapted legal frameworks persist. Despite these challenges, AI has the potential to democratize research and academic resources, and to shift pedagogies from rote learning to more critical, analytical, and creative thinking. The International Pharmaceutical Federation (FIP) supports a needs-based, outcome-focused approach to pharmacy education, which aligns with the potential of AI to enhance learning outcomes. However, several universities have banned AI's use, likely due to the rapid development of AI technology and the need for time to understand its ethical and legal implications. The article concludes that continuous research into the implications, benefits, and drawbacks of AI in academia is essential to inform new practices and policies in clinical pharmacy practice, research, and education.The article "Artificial Intelligence in Academic Writing and Clinical Pharmacy Education: Consequences and Opportunities" by Anita Elaine Weidmann explores the ongoing debate surrounding the use of artificial intelligence (AI) in academic research and teaching. The launch of ChatGPT in November 2022 has sparked discussions on ethical considerations, academic integrity, authorship, and the need for new legal frameworks. AI tools can enhance time efficiency, promote critical thinking, and improve drug discovery, clinical decision-making, and guideline development, potentially benefiting patient safety. However, concerns about plagiarism, authorship, and the need for adapted legal frameworks persist. Despite these challenges, AI has the potential to democratize research and academic resources, and to shift pedagogies from rote learning to more critical, analytical, and creative thinking. The International Pharmaceutical Federation (FIP) supports a needs-based, outcome-focused approach to pharmacy education, which aligns with the potential of AI to enhance learning outcomes. However, several universities have banned AI's use, likely due to the rapid development of AI technology and the need for time to understand its ethical and legal implications. The article concludes that continuous research into the implications, benefits, and drawbacks of AI in academia is essential to inform new practices and policies in clinical pharmacy practice, research, and education.